|
|
H2019/4435/150ER
|
INVEGA SUSTENNA
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2019/4434/152ER
|
INVEGA SUSTENNA 117
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2019/4433/151ER
|
INVEGA SUSTENNA 78
|
PALIPERIDONE PALMITATE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2018/4832/173ER
|
INVEGA® 9 MG PROLONGED-RELEASE TABLETS
|
PALIPERIDONE
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
H2018/CTD4469/157ER
|
VOKANAMET
|
CANAGLIFLOZIN / METFORMIN
|
PHILLIPS PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2025/CTD7147/13381
|
ZYTIGA®
|
ABIRATERONE ACETATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2017/CTD3785/116
|
ZYTIGA
|
ABIRATERORONE ACETATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2015/CTD3938/468
|
INTELENCE 25 MG
|
ETRAVIRINE
|
Janssen-Cilag International NV
|
Withdrawn Voluntarily by MAH
|
Details →
|
|
|
CTD 4713
|
INVOKANA 100MG
|
CANAGLIFLOZIN
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
4714
|
INVOKANA 300MG
|
CANAGLIFLOZIN
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H93/312
|
EPREX PROTECS 10000U
|
EPOETIN ALFA
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
H2022/CTD6606/22832
|
TREVICTA® 175MG
|
PALIPERIDONE PALMITATE
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2022/CTD6609/12835
|
TREVICTA® 263MG
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2022/CTD6616/12877
|
TREVICTA® 350MG
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2022/CTD6626/12895
|
TREVICTA® 525MG
|
PALIPERIDONE PALMITATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2016/CTD3786/424
|
VELCADE®
|
BORTEZOMIB
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
12885/R1
|
PARIET 20 MG
|
RABEPRAZOLE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2015/CTD2306/305/R1
|
PREZISTA 150 mg
|
Darunavir
|
Janssen-Cilag International NV
|
Retained
|
Details →
|
|
|
H2016/CTD3706/633
|
PREZISTA 400 MG
|
DARUNAVIR
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2012/CTD159/443/R1
|
PREZISTA 600mg
|
Darunavir
|
Janssen-Cilag International NV
|
Retained
|
Details →
|